Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
16 hedge funds and large institutions have $3.77M invested in Orgenesis Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.
6% more capital invested
Capital invested by funds: $3.57M → $3.77M (+$201K)
11% less funds holding
Funds holding: 18 → 16 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
+$537K |
| 2 |
DG
Delek Group
Herzliya,
Israel
|
+$289K |
| 3 |
BlackRock
New York
|
+$156K |
| 4 |
Cerity Partners
New York
|
+$90.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
-$208K |
| 2 |
Squarepoint
New York
|
-$103K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$68K |
| 4 |
WEC
Winslow Evans & Crocker
Boston,
Massachusetts
|
-$6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
ORGS Hedge Fund Activity: Q2 2019 in Review
16 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2019, worth a combined $3.77M — up 5.6% from $3.57M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ORGS and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 6 added.
The largest buyer was Venator Capital Management, adding an estimated $537K. The largest seller was Cheyne Capital Management (UK), exiting entirely with an estimated $208K sold.
- 16 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2019, down from 18 in Q1 2019.
- Funds reported $3.77M of Orgenesis Inc. Common Stock stock for Q2 2019, up 5.6% quarter-over-quarter.
- 3 funds opened new Orgenesis Inc. Common Stock positions in Q2 2019 and 5 closed out, a net change of -2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q2 2019 was Venator Capital Management, an estimated $537K added.
- The largest Orgenesis Inc. Common Stock seller in Q2 2019 was Cheyne Capital Management (UK), an estimated $208K sold.
Based on aggregated 13F filings for Q2 2019.